Reading Time: 4 minutesThe exact course, duration and rate of progression of MND often varies greatly from person to person; even when there is a known family history
Category: News
Reading Time: 3 minutesAfter we posted yesterday’s blog (Thursday 10 October) about Giovanna Mallucci’s research in Leicester, we received a report on the story from the President of the
Reading Time: 3 minutesMND Association-funded researcher Dr Sharon Abrahams (University of Edinburgh) has recently published an article on the Edinburgh Cognitive ALS Screen (ECAS) in the prestigious journal
Reading Time: 4 minutesA toxin known as β-N-methylamino-l-alanine (BMAA), which is found in blue-green algae, has been shown to cause proteins inside cells to clump together and cause cell
Reading Time: 2 minutesSummer has gone and autumn has arrived, which means it is time to open our Online Summary Application Form for our next round of research
Reading Time: 4 minutesThe only ‘proven’ treatment to slow the progression of MND is Riluzole. There are, however, many organisations offering expensive ‘unproven’ and ‘alternative’ treatments for MND.
Reading Time: < 1 minuteDr Richard Mead based at the Sheffield Institute for Translational Neuroscience (SITraN) at the University of Sheffield has been awarded the Kenneth Snowman-MND Association Lectureship
Reading Time: 4 minutesAfter a brilliant first day at ENCALS, which included a talk by Dr Johannes Brettschneider, the second day began with a talk by Thierry Latran